Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
| Current price | $27.46 | 52-week high | $153.56 |
| Prev. close | $26.12 | 52-week low | $23.15 |
| Day low | $26.12 | Volume | 8,525,800 |
| Day high | $27.55 | Avg. volume | 11,578,311 |
| 50-day MA | $26.44 | Dividend yield | N/A |
| 200-day MA | $42.74 | Market Cap | 10.62B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
MRNA Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MRNA Price Returns
| 1-mo | 12.63% |
| 3-mo | -22.89% |
| 6-mo | -39.85% |
| 1-year | -81.82% |
| 3-year | -81.51% |
| 5-year | -53.54% |
| YTD | -33.96% |
| 2024 | -58.19% |
| 2023 | -44.63% |
| 2022 | -29.28% |
| 2021 | 143.11% |
| 2020 | 434.10% |